Lisata Therapeutics Inc. (LSTA)
NASDAQ · Healthcare
Lisata Therapeutics Inc. Shareholder Equity 2010–2025
Lisata Therapeutics Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lisata Therapeutics Inc. shareholder equity as of December 31, 2025: 14.9M, a 49.76% decrease year-over-year.
- Lisata Therapeutics Inc. shareholder equity for 2025 were 14.9M, a 49.76% decrease from 2024.
- Lisata Therapeutics Inc. shareholder equity for 2024 were 29.6M, a 38.58% decrease from 2023.
- Lisata Therapeutics Inc. shareholder equity for 2023 were 48.1M, a 27.68% decrease from 2022.
- Lisata Therapeutics Inc. shareholder equity for 2022 were 66.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lisata Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $30 |
| 2023 | $48 |
| 2022 | $67 |
| 2016 | $5 |
| 2015 | $24 |
| 2014 | $59 |
| 2013 | $63 |
| 2012 | $33 |
| 2011 | $62 |
| 2010 | $49 |
Lisata Therapeutics Inc. Shareholder Equity — FAQ
Lisata Therapeutics Inc. (LSTA) shareholder equity over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LSTA's shareholder equity history?
The chart and table above show Lisata Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.